1,2-dimethylhydrazine has been researched along with pioglitazone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Jin, Z; Li, J; Lv, Y | 1 |
Han, YJ; Jin, Z; Li, CF; Li, J; Lv, YM; Zhang, YP | 1 |
Sethi, S; Sinha, VR | 1 |
3 other study(ies) available for 1,2-dimethylhydrazine and pioglitazone
Article | Year |
---|---|
[Pioglitazone, a peroxisome proliferators-activated receptor gamma ligand, inhibits dimethylhydrazine (DMH) induced aberrant crypt foci in rats].
Topics: 1,2-Dimethylhydrazine; Aberrant Crypt Foci; Animals; Colonic Neoplasms; Female; Intestinal Mucosa; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Sulindac; Thiazolidinediones | 2003 |
[Role of peroxisome proliferators-activated receptor-gamma in the chemical prevention therapy of sulindac for precancerous lesions of rats].
Topics: 1,2-Dimethylhydrazine; Anilides; Animals; Colorectal Neoplasms; Male; Pioglitazone; PPAR gamma; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Sulindac; Thiazolidinediones | 2009 |
Pioglitazone hydrochloride: chemopreventive potential and development of site-specific drug delivery systems.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Cell Proliferation; Colon; Colonic Neoplasms; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; HCT116 Cells; Humans; Intestinal Mucosa; Male; Pioglitazone; Rats, Wistar; Tablets, Enteric-Coated; Thiazolidinediones | 2015 |